![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Northwestern University |
---|---|
Information provided by: | Northwestern University |
ClinicalTrials.gov Identifier: | NCT00509886 |
The purpose of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.
Condition | Intervention |
---|---|
Hyperhidrosis Excess Sweating |
Drug: Drysol Drug: Drioff |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double Blind (Subject, Investigator), Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Non-Prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating |
Enrollment: | 24 |
Study Start Date: | June 2007 |
Study Completion Date: | April 2008 |
Primary Completion Date: | September 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
ARMs were randomized. One side of the body received treatment with one antiperspirant and the contralateral side with a different antiperspirant.
|
Drug: Drysol
20% aluminum chloride hexahydrate
|
2: Experimental
ARMs were randomized. One side of the body received treatment with one antiperspirant and the contralateral side with a different antiperspirant.
|
Drug: Drioff
1% aluminum acetate
|
The objective of this study is to assess the effectiveness of the prescription treatment compared to the non-prescription treatment. It is hypothesized that the prescription treatment will have a significantly greater effect than the non-prescription treatment on decreasing excess sweating.
Ages Eligible for Study: | 21 Years to 30 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Illinois | |
Northwestern University Dermatology | |
Chicago, Illinois, United States, 60611 | |
Northwestern University Dermatology | |
Chicago, Illinois, United States, 60611 |
Principal Investigator: | Murad Alam, MD | Northwestern University dermatology |
Study Chair: | Jillian A Havey | Northwestern University Feinberg School of Medicine |
Study Director: | Dennis West, PhD | Northwestern University dermatology |
Study Director: | Sara Ortiz | Northwestern University dermatology |
Study Director: | Nicolle Martin, MD | Northwestern University Dermatology |
Responsible Party: | Northwestern University Dermatology department ( Murad Alam, MD ) |
Study ID Numbers: | STU00000722 |
Study First Received: | July 31, 2007 |
Last Updated: | April 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00509886 |
Health Authority: | United States: Institutional Review Board |
Skin Diseases Hyperhidrosis |
Sweat Gland Diseases |